Introduction to Vonoprazan Tablets 20 mg (Vonoref-20)

Vonoprazan is an advanced potassium-competitive acid blocker (P-CAB) that provides superior acid suppression compared to traditional proton pump inhibitors (PPIs). It effectively treats acid-related disorders, including gastroesophageal reflux disease (GERD), peptic ulcers, and Helicobacter pylori infections.

Biophar Group proudly offers Vonoref-20 (Vonoprazan 20 mg Tablets) for PCD Pharma Franchise & Third-Party Manufacturing across India, ensuring access to high-quality acid-suppressing medication.

Mechanism of Action

Vonoprazan directly inhibits the H+/K+ ATPase enzyme in the stomach, reducing acid secretion more rapidly and consistently than PPIs. Unlike traditional PPIs, it does not require activation in an acidic environment, leading to faster symptom relief and prolonged acid suppression.

best pcd pharma and third-party manufacturing companies in Latur and Mumbai City

Indications and Uses of Vonoprazan Tablets 20 mg

Vonoref-20 is prescribed for the following acid-related conditions:

• Gastroesophageal Reflux Disease (GERD): Provides long-term relief from acid reflux and heartburn.
• Peptic Ulcers: Promotes healing of gastric and duodenal ulcers.
• Helicobacter pylori Eradication: Used with antibiotics to completely eradicate H. pylori infections.
• NSAID-Induced Ulcers: Helps prevent and treat ulcers caused by prolonged NSAID use.
• Zollinger-Ellison Syndrome: Manages excessive gastric acid secretion.

Advantages of Vonoprazan Over Traditional PPIs

• Faster Onset of Action

Begins reducing acid production within one hour of administration.

• Superior and Sustained Acid Suppression

Maintains near-neutral gastric pH for an extended duration, preventing nighttime acid breakthrough.

• No Need for Acid Activation

Works independently of gastric pH, ensuring more stable and predictable acid control.

• Effective in PPI-Resistant Cases

Provides relief for patients who do not respond to standard PPIs.

• Higher H. Pylori Eradication Rates

Demonstrates better success rates compared to traditional PPI-based regimens.

Dosage and Administration

• For GERD & Peptic Ulcers: One 20 mg tablet daily, preferably before meals.
• For H. pylori eradication: one 20 mg tablet twice daily with appropriate antibiotics.
• For NSAID-Induced Ulcer Prevention: One 20 mg tablet once daily.

Side Effects and Precautions

Common Side Effects:

• Nausea
• Abdominal pain
• Diarrhea
• Headache

Rare but serious side effects:

• Liver dysfunction
• Vitamin B12 deficiency with long-term use
• Hypomagnesemia (low magnesium levels)
• Increased risk of gut infections

Precautions:

• Not recommended for pregnant or breastfeeding women unless prescribed by a doctor.
• Patients with liver or kidney disorders should use Vonoprazan with caution.
• Long-term use should be monitored for nutritional deficiencies and bone health concerns.

PCD Pharma Franchise and Third-Party Manufacturing by Biophar Group

Biophar Group offers Vonoref-20 across India through PCD Pharma Franchise and Third-Party Manufacturing, creating lucrative business opportunities for pharmaceutical distributors, stockists, and entrepreneurs.

Benefits of Partnering with Biophar Group

• Monopoly Rights: Exclusive distribution rights in designated regions.
• High-Quality Manufacturing: WHO-GMP-certified facilities ensure superior pharmaceutical standards.
• Marketing & Promotional Support: Includes free promotional materials, visual aids, product samples, and MR bags.
• Affordable Pricing: Competitive rates to maximize profit margins.
• Timely Delivery: Efficient logistics ensure prompt supply.

How to Apply for a PCD Pharma Franchise or Third-Party Manufacturing?

If you are interested in distributing Vonoref-20 (Vonoprazan 20 mg Tablets) through PCD Pharma Franchise or Third-Party Manufacturing, follow these steps:

1. Contact Biophar Group via a website or customer support.
2. Discuss business terms, including investment requirements, product portfolio, and pricing.
3. Complete legal documentation (GST, drug license, agreement papers).
4. Place your order and receive high-quality Vonoref-20 stock promptly.

Conclusion

Vonoref-20 (Vonoprazan 20 mg) is a breakthrough acid suppressant offering faster, stronger, and more consistent acid control than traditional PPIs. Manufactured by HETER and distributed by Biophar Group, it is now available for PCD Pharma Franchise and Third-Party Manufacturing across India.

Pharma professionals and distributors looking for a high-demand, high-margin product can confidently invest in Vonoref-20 for a profitable and sustainable business opportunity.

Top pcd pharma franchise companies in Mumbai Suburban and Nanded

Contact Us

Best PCD Pharma Franchise & Third-Party Pharma Manufacturing Company in India

📞 Contact: +91-9888871967
✉ Email: Biophar.purchase@gmail.com